Brief: Pa Shun Pharmaceutical International sees hy profit attributable to decline more than 60 pct
June 30 (Reuters) - Pa Shun Pharmaceutical International
Holdings Ltd 0574.HK
* Expected that group's hy profit attributable will record a
decline of more than 60%
* Expected result due to "two-invoice" system implemented in
april 2017 in sichuan
Source text for Eikon: ID:nHKS9fnYzH
Further company coverage: 0574.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Pa Shun International Holdings
See all newsBrief: Pa Shun International Says Hearing Of Petition Adjourned To November 4, 2026
Brief: Pa Shun International Holdings Says Winding-Up Petition Hearing Adjourned
Brief: PA Shun International Fails To Pay 2025 Yearly Payments Of HK$10 Million By June 30
Brief: Trading In Shares Of PA Shun International Holdings Halted At 90 A.M. On July 2, 2026, HKEX Says
Brief: PA Shun International Says Petition Was Filed By Underdog Consulting Against Company